Wytensin

Known as: Wyeth Ayerst of Guanabenz Acetate, Wyeth-Ayerst of Guanabenz Acetate, Acetate Wyeth-Ayerst, Guanabenz 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2008
0119832008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
In cystic fibrosis respiratory epithelial cells, the absence or dysfunction of the chloride channel CFTR (Cystic Fibrosis… (More)
Is this relevant?
2003
2003
Guanabenz (2,6-dichlorobenzylidene-amino-guanidine) is a centrally acting antihypertensive drug whose mechanism of action is via… (More)
Is this relevant?
1998
1998
Guanabenz (Wytensin) was shown to inactivate nitric oxide synthase (NOS) activity in vitro and in vivo. In in vitro studies with… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 3
Is this relevant?
1996
1996
The N-reduction of the centrally acting alpha 2-adrenoreceptor agonist guanoxabenz (Benzérial), an N-hydroxyamidinohydrazone, to… (More)
Is this relevant?
1994
1994
Guanabenz (Wytensin Wyeth-Ayerst Laboratories, Philadelphia, PA) is a centrally acting alpha 2 adrenergic agonist. Guanabenz… (More)
Is this relevant?
1983
1983
  • The Medical letter on drugs and therapeutics
  • 1983
 
Is this relevant?